Malignant Pleural Effusion: Causes, Symptoms, and Treatment Options

Malignant Pleural Effusion: Causes, Symptoms, and Treatment Options

• Medically reviewed by
  Dr. Parveen Yadav
  18+ Yrs Exp | 5,700+ Thoracic & Robotic Cancer Surgeries
• Aug 28, 2026

A malignant pleural effusion is a build-up of fluid around the lung caused directly by cancer, most often lung cancer, breast cancer, or cancer that has spread from another organ. It is one of the most common reasons a cancer patient suddenly develops breathlessness, and the fluid usually keeps coming back unless it is specifically treated, not just drained once. The right treatment depends less on how much fluid is present and more on how well the lung re-expands once the fluid is removed, and what the overall cancer treatment plan looks like.

This guide explains why malignant pleural effusion happens, how it is diagnosed, and the treatment options doctors choose between, including thoracentesis, talc pleurodesis, and indwelling pleural catheters such as PleurX.

What Is a Malignant Pleural Effusion?

The pleura is the thin lining around the lung and inside the chest wall. Normally it holds only a small amount of fluid that helps the lung glide smoothly during breathing. A pleural effusion develops when fluid builds up beyond this small amount.

A pleural effusion is called malignant when cancer cells are found directly in the fluid or on the pleural lining itself, meaning the cancer has spread to the pleura. This is different from a pleural effusion caused indirectly by a tumour blocking lymphatic drainage or by pneumonia, heart failure, or low protein levels, which are managed very differently.

What Causes Malignant Pleural Effusion?

Almost any cancer can spread to the pleura, but a small number of cancers account for most cases.

• Lung cancer: The single most common cause, since the pleura sits directly against the lung.
• Breast cancer: A very common cause in women, sometimes appearing years after the original breast cancer treatment.
• Lymphoma: Can involve the pleura as part of more widespread disease.
• Ovarian and other gastrointestinal cancers: Less common but well recognised causes.
• Mesothelioma: A cancer that starts in the pleura itself rather than spreading there from elsewhere.
• Unknown primary: In some patients, the pleural fluid is the first sign of cancer, and the original site is found only after further testing.

Symptoms of Malignant Pleural Effusion

Symptoms depend on how quickly the fluid has built up and how much is present, since a slowly accumulating effusion can sometimes reach a large volume before symptoms become severe.

• Progressive breathlessness, often the main symptom
• A feeling of chest heaviness or dull ache on the affected side
• A dry cough
• Reduced ability to lie flat comfortably
• Fatigue, sometimes out of proportion to how the underlying cancer is otherwise being controlled

Because breathlessness in a cancer patient can also come from anaemia, cancer-related fatigue, lung involvement by the cancer itself, or unrelated heart or lung disease, imaging is needed to confirm that a pleural effusion is the specific cause before planning drainage.

How Is Malignant Pleural Effusion Diagnosed?

• Chest X-ray: Usually the first test, showing fluid in the pleural space, though it does not confirm whether the fluid is malignant.
• Ultrasound of the chest: Helps estimate fluid volume, guide safe drainage, and check whether the lung re-expands once fluid is removed, which strongly influences treatment choice.
• CT scan of the chest: Shows the extent of pleural involvement, other sites of disease, and helps rule out other causes of the effusion.
• Pleural fluid analysis (thoracentesis with cytology): A sample of fluid is drawn with a needle and sent for cytology to look for cancer cells, along with routine tests to rule out infection.
• Pleural biopsy: Considered if fluid cytology is negative but suspicion of pleural cancer involvement remains high.

Malignant Pleural Effusion Treatment Options

There is no single "best" treatment for every patient. The choice depends on how breathless the patient is, whether the lung fully re-expands after drainage, how much fluid reaccumulates, expected survival, and whether ongoing cancer treatment (chemotherapy, targeted therapy, or immunotherapy) is likely to control the fluid on its own.

• Therapeutic thoracentesis: Fluid is drained with a needle for immediate symptom relief. It is simple and low-risk but the fluid typically returns within days to a few weeks in most malignant effusions, so it is usually a first step rather than a definitive plan.
• Chemical (talc) pleurodesis: A sclerosing agent, most commonly sterile talc, is introduced into the pleural space, usually through a chest tube, to deliberately cause inflammation that fuses the lung to the chest wall and prevents fluid from re-accumulating. This generally requires a short hospital stay while the chest tube drains and the pleurodesis takes effect.
• Indwelling pleural catheter (IPC / PleurX): A thin, soft catheter is placed through the skin into the pleural space and left in place long-term. The patient or a caregiver drains the fluid at home on a set schedule using vacuum bottles, avoiding repeated hospital visits. In a meaningful proportion of patients, this approach also leads to spontaneous pleurodesis over time, after which the catheter can be removed.
• VATS (video-assisted thoracoscopic surgery) with talc poudrage: A minimally invasive surgical option that allows the surgeon to directly visualise the pleural space, drain fluid completely, take biopsies if needed, and apply talc under direct vision, often giving a higher pleurodesis success rate than chest-tube instillation alone.
• Systemic cancer treatment: In cancers that are highly responsive to chemotherapy, targeted therapy, or immunotherapy (such as certain lung cancers with specific mutations, or some lymphomas), controlling the underlying cancer can reduce or resolve the effusion without a separate pleural procedure.

Thoracentesis vs Talc Pleurodesis vs PleurX: How Doctors Choose

Lung re-expansion after drainage: Talc pleurodesis is favoured when the lung re-expands fully. PleurX catheter is favoured when the lung does not fully re-expand ("trapped lung").

Expected fluid reaccumulation: Slower reaccumulation favours talc pleurodesis, whereas fast, frequent reaccumulation favours PleurX.

Ability to tolerate a hospital stay: Talc pleurodesis suits patients fit for a short admission; PleurX is preferred for patients who wish to avoid a hospital stay or have limited mobility.

Access to home drainage support: PleurX requires a caregiver available to help with home drainage.

Neither option is universally "better." A patient whose lung does not re-expand after drainage (a trapped lung) will not benefit from pleurodesis, since the two pleural surfaces cannot properly fuse together, making an indwelling catheter the more logical choice in that specific situation.

Access to These Treatments in India

In India, chest tube-based talc pleurodesis remains the more widely available and commonly used option in most centres, partly because indwelling pleural catheters are imported devices and can be significantly more expensive, with less insurance coverage and fewer trained home-care nursing services to support long-term outpatient drainage compared to some Western healthcare systems.

VATS-guided talc poudrage is increasingly available at centres with thoracic surgery expertise and offers a practical, cost-effective alternative that combines direct visualisation, biopsy capability, and a high pleurodesis success rate in a single admission.

For patients who specifically need an indwelling catheter, for example those with a trapped lung, it is worth discussing availability and cost directly with your treating team early rather than after multiple failed drainage attempts.

What to Expect During Recovery

• After thoracentesis alone, most patients go home the same day with advice to watch for worsening breathlessness or chest pain.
• After talc pleurodesis, expect a hospital stay of a few days while the chest tube remains in place and drainage is monitored before removal.
• After PleurX catheter placement, a nurse or trained caregiver is taught to drain the catheter at home on a schedule, usually every one to two days initially.
• Mild fever, chest discomfort, or fatigue for a day or two after pleurodesis is common and usually settles with simple pain relief.
• Any new or worsening breathlessness, fever with chills, or redness and discharge at a catheter site should be reported to your care team promptly.

Final Thoughts

Malignant pleural effusion is a common and very treatable complication of advanced cancer, even when it cannot be cured outright, because relieving breathlessness meaningfully improves day-to-day quality of life. The right approach, whether that is talc pleurodesis, VATS with talc poudrage, or an indwelling pleural catheter, depends on how the lung behaves after drainage, practical factors like caregiver support, and where you are in your overall cancer treatment.

If you or a family member has developed breathlessness with a known or suspected pleural effusion, book a consultation with Dr. Parveen Yadav to review your scans and fluid reports and discuss which drainage strategy fits your specific situation. Bring your chest X-ray or CT scan and any prior fluid cytology reports to your appointment so the right approach can be planned without delay.

Related reading:

• Difference Between Empyema and Pleural Effusion
• Weight Loss & Fatigue: Could It Be Lung Cancer?
• Chest Pain That Won't Go Away: Heart or Lungs?
• Robotic Lobectomy vs. Traditional VATS: An Expert's Guide

For advanced lung cancer treatment options, see our Lung treatment page.